نتایج جستجو برای: remission maintenance therapy

تعداد نتایج: 804901  

Journal: :acta medica iranica 0
sahar taba taba vakili department of internal medicine, shahid beheshti university of medical sciences, tehran, iran. mohammad taher department of internal medicine, tehran university of medical sciences, tehran, iran. nasser ebrahimi daryani department of gastroenterology, imam khomeini hospital, tehran university of medical sciences, tehran, iran.

the present treatment goals for inflammatory bowel diseases (ibd) especially ulcerative colitis (uc) include rapid induction of clinical remission, steroid-free maintenance of clinical remission, mucosal healing and improvement of quality of life in uc patients. immunomodulators have been reserved for steroid- dependent or steroid- refractory uc patients. among these agents, azathioprine/6-merc...

Journal: :international journal of hematology-oncology and stem cell research 0
kamran alimoghaddam mohamad jahani seyyedasadollah mousavi babak bahar amirali hamidieh mohammad vaezi

introduction: despite achievement to complete remission (cr) with current treatments and new multiple chemotherapeutic agents in acute lymphoblastic leukemia (all) patients, the majority of them still relapse during long-term follow-up. the use of post- remission therapy will reduce early relapse in these cases, but the best option is still debatable. patients and methods: in this retrospective...

Journal: :international journal of hematology-oncology and stem cell research 0
t azarm saied-alshohada medical center; isfahan university of medical siences; islamic republic of iran m jahani hematology- oncology and bone marrow transplantation research center, tehran university of medical sciences a.gh amini saied-alshohada medical center; isfahan university of medical siences; islamic republic of iran m.r saghfi hematology- oncology and bone marrow transplantation research center, tehran university of medical sciences

from 1365 to 1382, 205 cases of acute lymphoblastic leukemia (all) were refered to our center. 160 cases achived complete remission and entered our clinical trial of cns relapse which were under consideration. the patients included 98 men and 62 women with an average age of 32 years (range 4-61 years). 160 of 205 cases had complete remission with a rate about 78%.the latter group was entered in...

Extramedullary plasmacytoma occurs in 18% of patients with multiple myeloma. Laryngeal involvement in multiple myeloma is rare, and only a few cases have been reported. We present a case of a 44-year-old women with multiple myeloma who presented with stridor due to a mass involving the larynx which was initially proven to be plasmacytoma on biopsy. She had evidence of multiple myeloma of IgA la...

Journal: :Blood 1979
H D Preisler Y Rustum E S Henderson S Bjornsson P J Creaven D J Higby A Freeman S Gailani C Naeher

Patients with acute nonlymphocytic leukemia were given remission induction therapy consisting of cytosine arabinoside and an anthracycline. Those patients who experienced complete remission received two courses of consolidation therapy and were randomized to receive maintenance therapy consisting of either daily chemotherapy with reinforcements every 3 mo or reinforcement therapy only every 6 w...

Journal: :BMC Gastroenterology 2008
Bo Shen Feza H Remzi A Rocio Lopez Elaine Queener

BACKGROUND Pouchitis is the most common long-term complication of in patients with restorative proctocolectomy and ileal pouch-anal anastomosis. Patients often develop antibiotic-dependent form of pouchitis requiring long-term antibiotic therapy for remission maintenance. Rifaximin, an oral, non-systemic, broad-spectrum antibiotic with a favorable safety profile, may be a promising candidate ag...

Journal: :international journal of hematology-oncology and stem cell research 0
mozaffar aznab imam reza and taleghani hospitals, kermanshah university of medical sciences, kermanshah, iran kamran alimoghadam hematology-oncology and stem cell research center, tehran university of medical sciences, tehran, iran ardeshir ghavamzadeh hematology-oncology and stem cell research center, tehran university of medical sciences, tehran, iran ghobad salimi jafar navabi mari attai

introduction: arsenic has been used as an effective medicine in the treatment of severe promyelocytic leukemia in recurrence and resistance cases toward atra. in this study, it has been used as induction and maintenance therapy after remission. method & material: we studied 31 patients diagnosed by apl. a rsenic was started at a dose of 0.15 mg/kg (daily) until patient’s bone marrow remission.(...

Journal: :Internal medicine 1999
T Kosaka K Sawada K Ohnishi A Egashira M Yamamura N Tanida M Satomi T Shimoyama

Eighteen patients with active Crohn's disease were treated with one leukocytapheresis session per week for a five-week intensive therapy, decreasing to one leukocytapheresis session per month for five sessions of initial maintenance therapy. Nutritional indices, inflammatory reactions, flow cytometry profiles, and cytokine production were also assessed before and after the intensive and initial...

Journal: :Clinical journal of the American Society of Nephrology : CJASN 2014
William F Pendergraft Frank B Cortazar Julia Wenger Andrew P Murphy Eugene P Rhee Karen A Laliberte John L Niles

BACKGROUND AND OBJECTIVES Remission in the majority of ANCA vasculitis patients is not sustained after a single course of rituximab, and risk of relapse warrants development of a successful strategy to ensure durable remission. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS A retrospective analysis of ANCA vasculitis patients who underwent maintenance therapy using rituximab-induced continuous...

Journal: :Gastroenterology & hepatology 2011
Barrett G Levesque Sunanda V Kane

Crohn's disease (CD) is a chronic inflammatory condition that often requires lifelong medical therapy for the induction and maintenance of remission. Oral mesalamine (5-aminosalicylic acid [5-ASA]) therapy has several forms, which can be categorized into oral formulations and prodrugs. The ability to demonstrate the efficacy of 5-ASA is limited in most clinical trials by the nonspecific endpoin...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید